- Posted August 20, 2014 by
MAKING STRIDES AGAINST BREAST CANCER ACROSS SECOND LIFE
The theme for the 2014 Making Strides Against Breast Cancer Across Second Life is “Seasons of Pink”. Making Strides Against Breast Cancer Across Second Life is part of the American Cancer Society and Relay For Life of Second Life.
The 2014 Making Strides Committee is led by Jessii2009 Warrhol, Chair and Gem Sunkiller, Co-Chair.
About Breast Cancer:
Breast cancer is the most common cancer among women in the United States, other than skin cancer. It is the second leading cause of cancer death in women, after lung cancer.
The chance of a woman having invasive breast cancer some time during her life is about 1 in 8. The chance of dying from breast cancer is about 1 in 36. Breast cancer death rates have been going down. This is probably the result of finding the cancer earlier and better treatment. Right now there are more than 2.9 million breast cancer survivors in the United States.
Breast cancer also occurs in men. The American Cancer Society estimates for breast cancer in men in the United States for 2014 are:
About 2,360 new cases of invasive breast cancer will be diagnosed About 430 men will die from breast cancer
Breast cancer is about 100 times less common among men than among women. For men, the lifetime risk of getting breast cancer is about 1 in 1,000. The number of breast cancer cases in men relative to the population has been fairly stable over the last 30 years.
About Making Strides Against Breast Cancer:
Making Strides Against Breast Cancer or MSABC is the largest network of breast cancer awareness events in the nation, uniting more than 300 communities to finish the fight. Every breast cancer walk and event is an incredible and inspiring opportunity to honor those who have battled breast cancer, raise awareness about what we can do to reduce our breast cancer risk, and race money to help the American Cancer Society fight the disease with research, information, services, and access to mammograms for women who need them.
For more information please visit the sites below: